EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW
14,950
-580 (-3.73%)
At close: Feb 27, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 96.04B | 69.37B | 55.47B | 39.38B | 28.49B |
| 38.45% | 25.06% | 40.83% | 38.24% | - |
| 96.04B | 69.37B | 55.47B | 39.38B | 28.49B |
| 38.45% | 25.06% | 40.83% | 38.24% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 2.51B | 4.47B | 4.42B | 4.15B |
| -43.93% | 1.13% | 6.41% | - |
| 66.86B | 51.00B | 34.96B | 24.34B |
| 31.11% | 45.85% | 43.68% | - |
| 69.37B | 55.47B | 39.38B | 28.49B |
| 25.06% | 40.83% | 38.24% | - |
Source: S&P Global Market Intelligence.